TY - JOUR
T1 - Predicting personal cardiovascular disease risk based on family health history
T2 - Development of expert-based family criteria for the general population
AU - Dijkstra, Tetske
AU - van den Heuvel, Lieke M.
AU - van Tintelen, J. Peter
AU - van der Werf, Christian
AU - van Langen, Irene M.
AU - Christiaans, Imke
N1 - Funding Information:
This work was funded by the Dutch Heart Foundation (2019T111). The funding body was not involved in the conceptualisation nor the writing of the manuscript.
Publisher Copyright:
© 2023, The Author(s), under exclusive licence to European Society of Human Genetics.
PY - 2023/12
Y1 - 2023/12
N2 - In inherited and familial cardiovascular diseases (CVDs), relatives without current symptoms can still be at risk for early and preventable cardiovascular events. One way to help people evaluate their potential risk of CVD is through a risk-assessment tool based on family health history. However, family criteria including inherited CVD risk to be used by laypersons are non-existent. In this project, we employed a qualitative study design to develop expert-based family criteria for use in individual risk assessment. In the first phase of the project, we identified potential family criteria through an online focus group with physicians with expertise in monogenic and/or multifactorial CVDs. The family criteria from phase one were then used as input for a three-round Delphi procedure carried out in a larger group of expert physicians to reach consensus on appropriate criteria. This led to consensus on five family criteria that focus on cardiovascular events at young age (i.e., sudden death, any CVD, implantable cardioverter-defibrillator, aortic aneurysm) and/or an inherited CVD in one or more close relatives. We then applied these family criteria to a high-risk cohort from a clinical genetics department and demonstrated that they have substantial diagnostic accuracy. After further evaluation in a general population cohort, we decided to only use the family criteria for first-degree relatives. We plan to incorporate these family criteria into a digital tool for easy risk assessment by the public and, based on expert advice, will develop supporting information for general practitioners to act upon potential risks identified by the tool. [Figure not available: see fulltext.].
AB - In inherited and familial cardiovascular diseases (CVDs), relatives without current symptoms can still be at risk for early and preventable cardiovascular events. One way to help people evaluate their potential risk of CVD is through a risk-assessment tool based on family health history. However, family criteria including inherited CVD risk to be used by laypersons are non-existent. In this project, we employed a qualitative study design to develop expert-based family criteria for use in individual risk assessment. In the first phase of the project, we identified potential family criteria through an online focus group with physicians with expertise in monogenic and/or multifactorial CVDs. The family criteria from phase one were then used as input for a three-round Delphi procedure carried out in a larger group of expert physicians to reach consensus on appropriate criteria. This led to consensus on five family criteria that focus on cardiovascular events at young age (i.e., sudden death, any CVD, implantable cardioverter-defibrillator, aortic aneurysm) and/or an inherited CVD in one or more close relatives. We then applied these family criteria to a high-risk cohort from a clinical genetics department and demonstrated that they have substantial diagnostic accuracy. After further evaluation in a general population cohort, we decided to only use the family criteria for first-degree relatives. We plan to incorporate these family criteria into a digital tool for easy risk assessment by the public and, based on expert advice, will develop supporting information for general practitioners to act upon potential risks identified by the tool. [Figure not available: see fulltext.].
U2 - 10.1038/s41431-023-01334-8
DO - 10.1038/s41431-023-01334-8
M3 - Article
C2 - 36973393
AN - SCOPUS:85150988682
SN - 1018-4813
VL - 31
SP - 1381
EP - 1386
JO - European Journal of Human Genetics
JF - European Journal of Human Genetics
ER -